Quick Summary
Dragon’s Blood (Croton lechleri) is a plant traditionally used for its medicinal properties, especially for wound healing and antimicrobial effects. Despite traditional uses, current clinical evidence on its efficacy and safety in humans remains limited, with ongoing research exploring its phytochemicals and potential therapeutic effects.
What is it?
Dragon’s Blood refers to the red sap derived from the Croton lechleri tree, a species native to the Amazon rainforest and parts of Central and South America. The sap has long been valued in traditional medicine systems for topical and internal use.
Traditional Uses
Traditionally, Dragon’s Blood has been used for its wound healing and antimicrobial properties. It has also been applied to skin injuries and infections, and sometimes used internally for gastrointestinal issues.
Active Compounds
Croton lechleri contains various phytochemicals, including proanthocyanidins, phenolic compounds, alkaloids, and diterpenes. These constituents have demonstrated anti-inflammatory, antioxidant, and antimicrobial activities in laboratory studies.
Potential Benefits with Evidence Levels
- Wound healing and antimicrobial effects
Evidence level: Traditional use and preclinical studies
Summary: Dragon’s Blood has traditional use and some preclinical evidence supporting its antimicrobial and wound healing properties. However, no conclusive clinical trials have established its efficacy in humans. - Anti-inflammatory and antioxidant effects
Evidence level: Preclinical and phytochemical studies
Summary: Phytochemicals isolated from Croton lechleri have shown anti-inflammatory and antioxidant activities in vitro, suggesting potential dermocosmetic benefits, though clinical confirmation is lacking. - Anticancer potential
Evidence level: Preclinical studies
Summary: Some preclinical data indicate that compounds from Croton lechleri might have antitumor effects, but robust clinical evidence is not available. - Gastrointestinal symptom management in HIV
Evidence level: Limited clinical trial data in AIDS-related diarrhea
Summary: One herbal product containing a Croton lechleri derivative (SP-303) showed reduction of stool weight and abnormal stool frequency in AIDS patients with diarrhea. However, evidence is insufficient to confirm efficacy.
Side Effects
Reported adverse effects mainly come from herbal mixtures containing Croton lechleri, which have included higher rates of gastrointestinal symptoms such as stomach discomfort and diarrhea. These effects have not been isolated to Croton lechleri alone. No serious adverse effects with Croton lechleri monotherapy have been reported in the available literature.
Drug Interactions
There is insufficient clinical data on drug interactions with Croton lechleri. No specific documented interactions have been identified. Given the general concerns regarding herbal-drug interactions, caution is advised until further studies clarify its interaction profile.
Who Should Avoid It
No specific contraindications for Croton lechleri have been reported in the available clinical literature. However, use during pregnancy and breastfeeding is not recommended due to a lack of safety data. Individuals with sensitive gastrointestinal systems or those taking other herbal or pharmaceutical medications should consult healthcare professionals before use.
Evidence Limitations
The existing clinical evidence for Croton lechleri is limited, with most data arising from traditional use, phytochemical analyses, and preclinical studies. Few randomized controlled trials exist, often involving herbal mixtures where Croton lechleri’s isolated effects cannot be discerned. Larger, well-designed clinical trials are necessary to confirm efficacy, safety, drug interactions, and appropriate dosing.
References
- Liu JP, Manheimer E, Yang M. Herbal medicines for treating HIV infection and AIDS. (2005)
Nine randomized placebo-controlled trials involving different herbal products, including one with SP-303 derived from Croton lechleri, showed limited efficacy evidence and some adverse gastrointestinal effects. Conclusion: insufficient evidence to support herbal medicines in HIV. - Bi WP, Man HB, Man MQ. Efficacy and safety of herbal medicines in treating gastric ulcer: a review. (2014)
Review discussing herbal medicines including Croton lechleri in the context of digestive ailments, indicating possible antimicrobial and protective gastric mechanisms but limited human clinical data. - Antitumor effect of Croton lechleri Mull. Arg. (Euphorbiaceae) (2012)
Preclinical study exploring antitumor effects of Croton lechleri extracts with promising in vitro and in vivo data supporting further research. - Tiwari R, Mishra S, Chauhan A, Gulati P, Dhobi M. The Dawn till Dusk of phytopharmaceuticals. (2024)
Discusses phytopharmaceutical drug development challenges including standardization and scientific validation, applicable to Croton lechleri preparations. - Herbal medicines and their formulations have a large market at the global level… (2024)
Overview of challenges with herbal medicine evidence and regulation; relevant to Croton lechleri as a botanical with pending research status.
Last Reviewed
June 2024
Information Disclaimer: This page provides general information about Dragon’s Blood (Croton lechleri) based on currently available research. It is not intended to provide medical advice or treatment recommendations. Always consult a qualified healthcare professional before using herbal supplements or starting new treatments, especially if you have underlying health conditions or are taking other medications.